The DOI matches its Crossref record; 13 of the 15 references it cites were found in a registry or an index; 1 of the 9 sources its claims cite were checked for support.
National blood donor vigilance programme of India
Open accessAbstract
INTRODUCTION: The donor vigilance program is intended to collect and assess information on unexpected or undesirable effects or reactions resulting from blood donation. In this report, we discuss the analysis of the blood donor adverse reactions (DARs) reported in the National Blood Donor Vigilance Programme of India during the first 2 years of implementation. MATERIALS AND METHODS: DAR reporting form prepared and approved by the National Executive Committee of the Haemovigilance Programme of India was used to capture the data by the blood centers and submitted to Donor-Vigil software prepared and hosted by the official website of the National Institute of Biologicals. Data reported for the years 2016 and 2017 were reviewed, analyzed, and validated by independent transfusion medicine experts. RESULTS: During this period, a total of 19,98,101 donations denominator data were reported, in which 1,622,600 (80.9%) were valid. A total of 6091 DARs were reported, out of which 3980 (65.35%) were found valid. Only validated numerator and denominator data were included in the analysis. Generalized DARs were the most common type of DARs reported (83.7%), followed by “others” type (7.7%), localized (7.6%), allergic (0.4%), and complications related to apheresis (0.4%). The overall DAR rate was 2.45/1000 blood donations, which was higher in apheresis donations (3.07/1000) as compared to whole blood donations (2.39/1000). The DARs rates were higher in females (3.5/1000) compared to male donors (2.3/1000) and in the first time (2.5/1000) compared to repeat donors (2.15/1000). CONCLUSION: In this report, we concluded that younger age, first time, and female donors are more prone to DARs as compared to older age, repeat, and male donors. During the analysis of the data, we found some limitations, which can be improved by upgrading the reporting form and conducting regular continuing medical education (CMEs) of participant blood centers.
Overview
CoChat Summary
TL;DR
This analysis of India’s National Blood Donor Vigilance Programme for 2016–2017 found an overall donor adverse reaction rate of 2.45 per 1000 valid donations, with generalized reactions most common. Younger, first-time, and female donors were more prone to donor adverse reactions.
Key findings
- Of 1,998,101 reported donations, 1,622,600 (80.9%) were valid; of 6,091 donor adverse reaction reports, 3,980 (65.35%) were valid. The overall DAR rate was 2.45/1000 blood donations.
- Generalized DARs were most common (83.7%; 3,328/3,980), followed by “others” (7.7%), localized (7.6%), allergic (0.4%), and apheresis-related complications (0.4%). Hematoma was the most common localized reaction (207/305).
- DAR rates were higher in apheresis donations (3.07/1000) than whole blood donations (2.39/1000), in females (3.5/1000) than males (2.3/1000), and in first-time donors (2.5/1000) than repeat donors (2.15/1000).
- Younger age, first-time, and female donors were more prone to DARs. Severe vasovagal reactions, defined by loss of consciousness or injury, accounted for 26.8% of generalized DARs; no serious DARs or deaths were reported.
Methods
- Retrospective analysis of DARs reported to the Donor-Vigil software from January 2016 to December 2017 for allogeneic donations, using numerator DAR parameters and denominator donation data.
- The DAR reporting form was approved by the National Executive Committee of the Haemovigilance Programme of India; definitions were adopted from ISBT/IHN/AABB standards. Data were validated by independent transfusion medicine experts and analyzed in R version 4.1.0 and Microsoft Excel 2016.
Limitations
- The paper states that limitations were found and recommends upgrading the reporting form and conducting regular continuing medical education for participant blood centers; it also notes underreporting, few participating centers, inappropriate reporting, retrospective analysis, and lack of age denominator data.
- Evident from the text: 18.79% of donation denominator data and 34.6% of numerator reports were excluded due to errors or discrepancies, and underreporting from blood donation camps is repeatedly noted.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Distribution of all the total validated donor adverse reactions reports of 2016 and 2017 (n = 3980 [1009 + 2971])](https://figures.cochat.ai/paper-figures/a15540974a314870bb9ec1ccf6e9b03a/national-blood-donor-vigilance-programme-of-india-figure-4.jpg)
Verification
Claims the paper makes
0 Valid · 1 Not valid · 8 Not checked · 76 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Donors aged between 18 and 30 years and weight >55 kg contributed to as high as 69% and 88.9% of all the reported DARs, respectively [Tables 5 and 6].”
§ National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017) > Results > Demographic analysis of donors with donor adverse reactions
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean age and weight of blood donors who experienced DARs were 28.26 ± 7.6 years and 68 ± 10.89 kg, respectively [Table 4].”
§ National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017) > Results > Demographic analysis of donors with donor adverse reactions
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in the first time (2.5/1000) compared to repeat donors (2.15/1000).”
- Also stated in: § Discussion · plain
“in first-time donors (2.59 every 1000 donations) as compared to repeat (2.15 every 1000 donations)”
§ National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017) > Abstract > RESULTS:
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The DARs rates were higher in females (3.5/1000) compared to male donors (2.3/1000)”
- Also stated in: § Discussion · plain
“higher in female donors (3.58 every 1000 donations) as compared to male (2.32 every 1000 donations)”
§ National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017) > Abstract > RESULTS:
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“with the most common as generalized DARs (2.05/1000).”
§ National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017) > Results > Distribution and categories of donor adverse reactions reported
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
35 more claims
Create a free account to see all 85 claims and every source verdict.
- Probably not a substantial claim. 13
- It may state two separate claims as one. 33
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017) > Abstract > CONCLUSION:
“we concluded that younger age, first time, and female donors are more prone to DARs as compared to older age, repeat, and male donors.”
§ National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017) > Discussion
“Due to lack of data on the age of donors (denominator data), it cannot be commented that whether the rate of DARs is more in the younger age group of donors.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017) > Introduction
“the National Blood Donor Vigilance Programme (NBDVP) was launched on June 14, 2015.”
§ National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017) > Conclusion
“the Donor Vigilance Program was established in 2016”
Citations
Cites
Haemovigilance: An effective tool for improving transfusion practice
de Vries, R. R. P., Faber, J. ‐., Strengers, P. F. W., & Members of the Board of the International Haemovigilance Network (2011) · Vox Sanguinis · doi:10.1111/j.1423-0410.2010.01442.x · Cited by 139
Marwaha, N., Agnihotri, N., & Sharma, R. (2012) · Asian Journal of Transfusion Science · doi:10.4103/0973-6247.98922 · Cited by 62 · cited 2×
“3 GR (81) Agnihotri et al.[15] 2002‐2003 Chandigarh 37,896 2.”
BackgroundSelf-citationDevelopment of standard definitions for surveillance of complications related to blood donation
Goldman, M., Land, K. J., Robillard, P., & Wiersum‐Osselton, J. C. (2015) · Vox Sanguinis · doi:10.1111/vox.12323 · Cited by 57 · cited 1×
“Definitions for DAR or complications and events with temporal association with blood donation were adopted from the Standard for Surveillance of Complications related to blood donation prepared by the International Society of Blood Transfusion in collaboration with the International Haemovigilance Network and American…”
MethodAdverse reactions in whole blood donors: an Indian scenario.
(2011) · Europe PMC (PubMed Central) · doi:10.2450/2010.0002-10 · Cited by 34
Bisht, A., Marwaha, N., Kaur, R., et al. (2018) · Asian Journal of Transfusion Science · doi:10.4103/ajts.ajts_5_18 · Cited by 31 · cited 1×
“2 Asian Journal of Transfusion Science - Volume 15, Issue 1, January-June 2021 transfusion reactions was launched on December 10, 2012 and subsequently, the National Blood Donor Vigilance Programme (NBDVP) was launched on June 14, 2015.[2,3]”
BackgroundSelf-citationDogra, A., Sidhu, M., Dogra, M., & Raina, T. R. (2015) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-014-0396-y · Cited by 21 · cited 1×
“8) Dogra et al.[18] 2011‐2012 Jammu 29,524 0.”
Agarwal, R., Periyavan, S., Dhanya, R., Parmar, L., Sedai, A., Ankita, K., Vaish, A., Sharma, R., & Gowda, P. (2015) · Asian Journal of Transfusion Science · doi:10.4103/0973-6247.165840 · Cited by 19 · cited 1×
“7) Agarwal et al.[19] 2011‐2014 Karnataka 30,928 3.”
Agnihotri, N., & Agnihotri, A. (2015) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-015-0568-4 · Cited by 18 · cited 1×
“This has been observed that a prospective analysis usually reports a high incidence of DAR when compared to retrospective one[15,16,22] due to better data capturing on regular basis.”
BackgroundPrevalence of acute adverse reactions among whole blood donors: A 7 years study
Kumari, S. (2015) · Journal of Applied Hematology · doi:10.4103/1658-5127.171989 · Cited by 14 · cited 1×
“7) Kumari[14] 2007‐2014 Patiala 27,664 0.”
National blood donor vigilance programme: India
Bisht, A., Singh, S., & Marwaha, N. (2016) · Asian Journal of Transfusion Science · doi:10.4103/0973-6247.175384 · Cited by 12 · cited 1×
“2 Asian Journal of Transfusion Science - Volume 15, Issue 1, January-June 2021 transfusion reactions was launched on December 10, 2012 and subsequently, the National Blood Donor Vigilance Programme (NBDVP) was launched on June 14, 2015.[2,3]”
BackgroundSelf-citation
Research works printed but not linked: 1
- Rai, 2018, Adverse reaction in whole blood donors at a tertiary care centre, Gwalior, IOSR Journal of Dental and Medical Sciences (IOSR-JDMS, 17, 31
Cited by
Meher, R., Patidar, G. K., Chaurasia, R., Pandey, H. C., & Hazarika, A. (2024) · Transfusion Medicine · doi:10.1111/tme.13026 · Cited by 10
Self-citationReporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!
Kaur, S., Mittal, K., Kaur, R., Kaur, G., Kaur, P., & Sood, T. (2021) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2021.11.003 · Cited by 5
Sociodemographic Factors Related to Adverse Donor Reactions in Shenzhen
Sun, L., Yu, Q., He, C.-M., & Wang, S. ‐. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s443682 · Cited by 4
Contact dermatitis to a topical formulation of heparin in a blood donor
Chand, S., Mallhi, R. S., & Philip, J. (2024) · Asian Journal of Transfusion Science · doi:10.4103/ajts.ajts_124_23 · Cited by 1
Shah, M. B., Bhatnagar, N., Shah, S. D., Ahuja, U., Rajvanshi, R., Pandav, F., Patel, A. S., Gajera, D., Thakkar, G., & Garhewal, A. (2024) · Global Journal of Transfusion Medicine · doi:10.4103/gjtm.gjtm_42_24 · Cited by 1
Metadata
- Authors
- Bisht, A., Marwaha, N., Arora, S., Patidar, G. K., & Chhabra, R.
- Affiliations
- Ministry of Health and Family Welfare (IN)
- Post Graduate Institute of Medical Education and Research (IN)
- All India Institute of Medical Sciences (IN)
- Corresponding author
- Bisht, Akanksha
- Venue
- Asian Journal of Transfusion Science
- Published
- 2021-01
- Volume
- 15
- Issue
- 1
- Pages
- 1-11
- ISSN
- 0973-6247 (ISSN-L)
- PMC
- PMC8294431
- OpenAlex
- W3172074579
- Cited by
- 20
- References
- 15
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 8 · 2023: 2 · 2022: 4 · 2021: 1
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Asian Journal of Transfusion Science (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hematology › Blood donation and transfusion practices
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- hemovigilance, blood donation, apheresis, whole blood donation, donor characteristics, sex differences, first-time donors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: National blood donor vigilance programme of India. https://app.cochat.ai/papers/10.4103/ajts.ajts_195_20
- The paper
- Bisht, A., Marwaha, N., Arora, S., Patidar, G. K., & Chhabra, R. (2021). National blood donor vigilance programme of India. Asian Journal of Transfusion Science. https://doi.org/10.4103/ajts.ajts_195_20
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.